ADIM
MRNS

Alpha DNA Investment Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Alpha DNA Investment Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-49,664
Closed -$540K – 258
2023
Q4 		$540K Sell
49,664
-27,419
-36% -$298K 0.21% 99
2023
Q3 		$621K Buy
+77,083
New +$621K 0.25% 80